Verition Fund Management »

Cytokinetics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.8M 5.6M 1.59
2023-09-30 $5.5M 6.5k 853.10

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Cytokinetics

Wolverine Asset Management
Citadel Advisors
Balyasny Asset Management
D. E. Shaw & Co
Polygon Management
FMR
Sona Asset Management
DeepCurrents Investment Group
Millennium Management
Point72 Asset Management
State Street Corporation
Advent Capital Management
Flow State Investments
Partner Fund Management
Ameriprise Financial

View all funds holding Cytokinetics